Ignite Creation Date:
2025-12-25 @ 12:05 AM
Ignite Modification Date:
2026-06-06 @ 11:02 PM
Study NCT ID:
NCT01247558
Status:
COMPLETED
Last Update Posted:
2012-07-25
First Post:
2010-11-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Administrative Claims Analysis of Metanx® in Diabetic Peripheral Neuropathy
Sponsor:
Pamlab, L.L.C.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Diabetic Peripheral Neuropathy (DPN) | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Metanx® | View |
| None | diabetes | View |
| None | neuropathy | View |
| None | peripheral neurological disorder | View |
| None | peripheral circulation disorder | View |
| None | folic acid | View |
| None | folate | View |
| None | L-methylfolate | View |
| None | vitamin B6 | View |
| None | Pyridoxal 5'-phosphate | View |
| None | vitamin B12 | View |
| None | methylcobalamin | View |